IS5732A - Pharmaceutical preparation containing human interferon beta-1A (IFN-BETA-1A) - Google Patents
Pharmaceutical preparation containing human interferon beta-1A (IFN-BETA-1A)Info
- Publication number
- IS5732A IS5732A IS5732A IS5732A IS5732A IS 5732 A IS5732 A IS 5732A IS 5732 A IS5732 A IS 5732A IS 5732 A IS5732 A IS 5732A IS 5732 A IS5732 A IS 5732A
- Authority
- IS
- Iceland
- Prior art keywords
- beta
- ifn
- pharmaceutical preparation
- preparation containing
- containing human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/007242 WO1999062542A1 (en) | 1998-05-29 | 1998-05-29 | Recombinant human interferon beta-1a (ifn-beta-1a) formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5732A true IS5732A (en) | 2000-11-24 |
Family
ID=22266817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5732A IS5732A (en) | 1998-05-29 | 2000-11-24 | Pharmaceutical preparation containing human interferon beta-1A (IFN-BETA-1A) |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1082132A1 (en) |
| JP (1) | JP2002516874A (en) |
| KR (1) | KR20010052454A (en) |
| CN (1) | CN1299285A (en) |
| AU (1) | AU8822598A (en) |
| BR (1) | BR9815966A (en) |
| CA (1) | CA2333063A1 (en) |
| EA (1) | EA200001252A1 (en) |
| EE (1) | EE200000694A (en) |
| HU (1) | HUP0102241A2 (en) |
| IL (1) | IL139933A0 (en) |
| IS (1) | IS5732A (en) |
| NO (1) | NO20006022L (en) |
| SK (1) | SK17762000A3 (en) |
| TR (1) | TR200003521T2 (en) |
| WO (1) | WO1999062542A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020025304A1 (en) * | 2000-06-16 | 2002-02-28 | Croze Edward M. | Novel interferon for the treatment of multiple sclerosis |
| WO2002051403A1 (en) * | 2000-12-21 | 2002-07-04 | Resuscitek, Inc. | Compositions of stable t3 and methods of use thereof |
| CN1325651C (en) * | 2001-05-24 | 2007-07-11 | 大连金威基因技术有限公司 | High-efficiency expression and application of human recombinant interferon B |
| CN1535724B (en) * | 2003-04-23 | 2012-09-05 | 北京金迪克生物技术研究所 | New application of recombinant human interferon for preventing serious acute respiratory tract syndrome |
| WO2009073711A1 (en) * | 2007-12-04 | 2009-06-11 | Remedy Pharmaceuticals, Inc. | Improved formulations and methods for lyophilization and lyophilates provided thereby |
| WO2022056233A1 (en) * | 2020-09-12 | 2022-03-17 | Academia Sinica | Re-folded human serum albumin and use thereof for anti-tumor |
-
1998
- 1998-05-29 EP EP98939859A patent/EP1082132A1/en not_active Withdrawn
- 1998-05-29 EE EEP200000694A patent/EE200000694A/en unknown
- 1998-05-29 TR TR2000/03521T patent/TR200003521T2/en unknown
- 1998-05-29 CA CA002333063A patent/CA2333063A1/en not_active Abandoned
- 1998-05-29 IL IL13993398A patent/IL139933A0/en unknown
- 1998-05-29 BR BR9815966-6A patent/BR9815966A/en not_active IP Right Cessation
- 1998-05-29 KR KR1020007013481A patent/KR20010052454A/en not_active Application Discontinuation
- 1998-05-29 SK SK1776-2000A patent/SK17762000A3/en unknown
- 1998-05-29 JP JP2000551797A patent/JP2002516874A/en not_active Withdrawn
- 1998-05-29 CN CN98814145A patent/CN1299285A/en active Pending
- 1998-05-29 WO PCT/US1998/007242 patent/WO1999062542A1/en not_active Application Discontinuation
- 1998-05-29 AU AU88225/98A patent/AU8822598A/en not_active Abandoned
- 1998-05-29 HU HU0102241A patent/HUP0102241A2/en unknown
- 1998-05-29 EA EA200001252A patent/EA200001252A1/en unknown
-
2000
- 2000-11-24 IS IS5732A patent/IS5732A/en unknown
- 2000-11-28 NO NO20006022A patent/NO20006022L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9815966A (en) | 2001-02-28 |
| CN1299285A (en) | 2001-06-13 |
| AU8822598A (en) | 1999-12-20 |
| JP2002516874A (en) | 2002-06-11 |
| IL139933A0 (en) | 2002-02-10 |
| EA200001252A1 (en) | 2001-06-25 |
| EE200000694A (en) | 2002-06-17 |
| EP1082132A1 (en) | 2001-03-14 |
| WO1999062542A1 (en) | 1999-12-09 |
| NO20006022L (en) | 2001-01-26 |
| NO20006022D0 (en) | 2000-11-28 |
| SK17762000A3 (en) | 2001-07-10 |
| HUP0102241A2 (en) | 2001-10-28 |
| KR20010052454A (en) | 2001-06-25 |
| CA2333063A1 (en) | 1999-12-09 |
| TR200003521T2 (en) | 2001-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142531A0 (en) | Cyclic peptide compound, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0001186A3 (en) | Purine l-nucleosides,analogs and pharmaceutical compositions thereof | |
| ATE303131T1 (en) | COMPOSITIONS FOR NASAL ADMINISTRATION | |
| HUP0103265A3 (en) | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use | |
| HUP0100950A3 (en) | Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUP0104574A3 (en) | Analogues of glp-1, pharmaceutical compositions comprising thereof and their use | |
| HUP0400887A3 (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same | |
| IL137904A0 (en) | Peptide analogues of insulin and pharmaceutical compositions containing the same | |
| IL116512A0 (en) | Cyclic peptides their preparation and pharmaceutical compositions containing them | |
| HUP0202367A3 (en) | Fap-activated anti-tumor peptides, process for their preparation pharmaceutical compositions comprising thereof and their use | |
| HUP0001107A3 (en) | Monocyclic l-nucleosides, analogs and pharmaceutical compositions thereof | |
| HUP0104934A3 (en) | Peptide analogues of pacap, pharmaceutical compositions comprising thereof and their use | |
| HUP0103513A3 (en) | Novel amidine derivatives their preparation and application as medicines and pharmaceutical compositions containing same | |
| HUP0004560A3 (en) | Fracture healing using pthrp analogs | |
| EP1010705A4 (en) | Novel cyclic tetrapeptide derivatives and medicinal use thereof | |
| HUP0004628A3 (en) | Novel camptothecin tetracyclic analogues, preparation methods and pharmaceutical compositions containing them | |
| HUP0003592A3 (en) | Lh-rh peptide analogues, their use and pharmaceutical compositions containing them | |
| HUP0102579A3 (en) | Peptide antiangiogenic drugs, pharmaceutical compositions comprising thereof and their use | |
| HRP950612B1 (en) | PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | |
| HUP0105204A3 (en) | Substituted phenethylamine derivatives and pharmaceutical compositions containing them | |
| HK1044156A1 (en) | Camptothecin analogs and methods of preparation thereof. | |
| PL344834A1 (en) | Pharmaceutical levothyroxine preparation | |
| AP2001002371A0 (en) | Streptogramin derivatives preparation and compositions containing them | |
| IL116190A (en) | Eleutherobin, analogs thereof and pharmaceutical compositions containing them | |
| IS5732A (en) | Pharmaceutical preparation containing human interferon beta-1A (IFN-BETA-1A) |